[3rd generation ABL kinase inhibitor and Philadelphia chromosome positive leukemia]. [electronic resource]
- [Rinsho ketsueki] The Japanese journal of clinical hematology Oct 2013
- 1682-6 p. digital
Publication Type: Journal Article; Review
0485-1439
Animals Clinical Trials as Topic Fusion Proteins, bcr-abl--genetics Humans Imidazoles--chemistry Leukemia--diagnosis Philadelphia Chromosome--drug effects Protein Kinase Inhibitors--therapeutic use Pyridazines--chemistry